All Resources
Read all of the latest breakthroughs, insights, and news from Ginkgo.
BlogFebruary 13, 2024
House Select Committee Tours Ginkgo Bioworks, Previews Biofab1, Ginkgo’s New Integrated Data Generation Facility Set to Launch in 2025BlogSeptember 21, 2021
The End of the Beginning: Ginkgo Goes PublicBlogMay 14, 2021
Taking Ginkgo Public on NYSE:DNABlogJune 30, 2020
Needle in a Haystack: Looking for Compounds to Treat COVID-19BlogApril 17, 2020
Teaming Up to Improve Antibody Therapeutics for COVID-19BlogApril 15, 2020
Supporting COVID-19 mRNA Vaccine Development with ModernaBlogApril 10, 2020
Project Update: COVID-19 DNA SynthesisBlogMarch 24, 2020
Scaling Up Whole Genome Sequencing of COVID-19BlogMarch 22, 2020
Synthetic Biology (and beyond) Community response to COVID-19BlogMarch 20, 2020
Fighting COVID-19 by Synthesizing DNABlogMarch 17, 2020
$25M of Free Platform Access for COVID-19 Projects
